건강보험심사평가원 환자 표본 자료를 활용한 mupirocin 외래처방 패턴 분석 및 처방적절성 평가
Prescription Patterns and Appropriateness of Topical Mupirocin in Ambulatory Care using the Korean National Health Insurance Claims Database
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Mupirocin, a topical antimicrobial agent has been used for patients with methicillin-resistant Staphylococcus aureus and recently mupirocin resistance was issued in some studies. The objective of this study was to analyze prescription patterns of topical mupirocin, to evaluate appropriateness of prescriptions in the ambulatory setting, and to compare frequency of mupirocin usage in South Korea with that in United States. Methods: Topical mupirocin prescription patterns (the number of prescription anda prescription period), and appropriateness of prescription (including a prescription rate over 10 days, a repeat prescription rate within 30 days and a prescription rate within labeled indications) were analyzed using the 2012 Health Insurance and Review and Assessment service-National Patient Sample dataset of South Korea. The National Ambulatory Medical Care Survey dataset was used to quantify topical mupirocin prescription in United States for comparison. Results: In South Korea, the prescriptions rate for use over 10 days was 3%, the repeat prescription rate within 30 days was 8.87% and the prescription proportion within labeled indications was 33.84%. The most frequent diagnostic code was nonbacterial infection. The prescription rate per 1000 population of topical mupirocin in South Korea was calculated to be 46.07, whereas in United States was calculated to be 13.10. Conclusion: Topical mupirocin has been used frequently and inappropriately, so further studies are required to investigate the rationale behind such prescribing mupirocin patterns.
Abstract
Background: Mupirocin, a topical antimicrobial agent has been used for patients with methicillin-resistant Staphylococcus aureus and recently mupirocin resistance was issued in some studies. The objective of this study was to analyze prescription patterns of topical mupirocin, to evaluate appropriateness of prescriptions in the ambulatory setting, and to compare frequency of mupirocin usage in South Korea with that in United States. Methods: Topical mupirocin prescription patterns (the number of prescription anda prescription period), and appropriateness of prescription (including a prescription rate over 10 days, a repeat prescription rate within 30 days and a prescription rate within labeled indications) were analyzed using the 2012 Health Insurance and Review and Assessment service-National Patient Sample dataset of South Korea. The National Ambulatory Medical Care Survey dataset was used to quantify topical mupirocin prescription in United States for comparison. Results: In South Korea, the prescriptions rate for use over 10 days was 3%, the repeat prescription rate within 30 days was 8.87% and the prescription proportion within labeled indications was 33.84%. The most frequent diagnostic code was nonbacterial infection. The prescription rate per 1000 population of topical mupirocin in South Korea was calculated to be 46.07, whereas in United States was calculated to be 13.10. Conclusion: Topical mupirocin has been used frequently and inappropriately, so further studies are required to investigate the rationale behind such prescribing mupirocin patterns.
참고문헌 (23)
- Antimicrobial resistance global report on surveillance: 2014 summary, "World Health Organization", ~ (2014)
- Espersen F, "Resistance to antibiotics used in dermatological practice", Br J Dermatol, 139(Suppl 53), pp.4~8 (1998)
- Liu C, "Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children", Clin Infect Dis, 52, pp.e18~e55 (2011)
- "U.S. Food and Drug Administration"[URL]
- "Ministry of Food and Drug safety"[URL]
- Yoo JI, "Clonal dissemination and mupA gene polymorphism of mupirocin-resistant Staphylococcus aureus isolates from long-term-care facilities in South Korea", Antimicrob Agents Chemother, 50, pp.365~367 (2006)
- 박세영, "The Prevalence, Genotype and Antimicrobial Susceptibility of High- and Low-Level Mupirocin Resistant Methicillin-Resistant Staphylococcus aureus", Annals of Dermatology, 24(1), pp.32~38 (2012), 대한피부과학회
- 윤성희, "Drug utilization review of mupirocin ointment in a Korean university-affiliated hospital", The Korean Journal of Internal Medicine, 30(4), pp.515~520 (2015), 대한내과학회[DOI]
- Park SH, "Community-genotype strains of methicillin-resistant Staphylococcus aureus with high-level mupirocin resistance in a neonatal intensive care unit", Early Hum Dev, 89, pp.661~665 (2013)
- "Health Insurance and Review and Assessment service"[URL]
- Thomas V R, "Mupirocin-resistant methicillin-resistat staphylococcus aureus in Western Australia", Med J Aust, 161, pp.397~398 (1994)
- 김록영, "입원 환자 표본 개발에 관한 연구: 국민건강보험 청구자료를 중심으로", 보건행정학회지, 23(2), pp.152~161 (2013), 한국보건행정학회
- Klein RJ, "Healthy people 2010 criteria for data suppression", Healthy People 2010 Stat Notes 2002, 1~12 (2002)
- "Centers for Disease Control and Prevention"[URL]
- "Centers for Disease Control and Prevention"[URL]
- "Central Intelligence Agency" (2016)[URL]
- Kim L, "A guide for the utilization of health insurance review and assessment service national patient samples", Epidemiol Health, 36, pp.e2014008~ (2014)
- Ruxton GD, "The unequal variance t-test is an underused alternative to Student's t-test and the Mann-Whitney U test", Behavioral Ecology, 17, pp.688~690 (2006)
- "Korean Health Industry statistics System"[URL]
- Upton A, "Mupirocin and Staphylococcus aureus:a recent paradigm of emerging antibiotic resistance", J Antimicrob Chemother, 51, pp.613~617 (2003)
- McNeil JC, "Decreased susceptibilities to retapamulin, mupirocin, and chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children", Antimicrob Agents Chemother, 58, pp.2878~2883 (2014)
- dos Santos KRN, "Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals", Infection Control &Hospital Epidemiology, 17, pp.813~816 (1996)
- Biedenbach DJ, "Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study", Clin Ther, 36, pp.953~960 (2014)